-
Mashup Score: 0
After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.
Source: www.empr.comCategories: General Medicine NewsTweet
-
Mashup Score: 1FDA Seizes Several Hundred Units of Counterfeit Ozempic - 15 day(s) ago
The contents or quality of the counterfeit products have yet to be determined.
Source: www.empr.comCategories: General Medicine NewsTweet-
Counterfeit Ozempic was distributed around the US. The labels have an authentic lot number but include illegitimate serial numbers. https://t.co/4i78eQ0JCv
-
-
Mashup Score: 0CDC Urges Extra Measles Shot for Some US Travelers Amid Outbreak - 15 day(s) ago
The CDC has long urged vaccination for international travelers, but the recommendation for domestic travelers is a response to the ongoing outbreaks across the US.
Source: www.empr.comCategories: General Medicine NewsTweet-
People traveling to or living in areas with transmission may need to get a second dose if they’ve only had one or getting vaccinated if they haven’t had any shots. https://t.co/hoDoTdEAk2
-
-
Mashup Score: 0MPR Weekly Dose Podcast #232 - 18 day(s) ago
Uplizna gains new indication; Vanrafia approved for proteinuria in IgAN; Erzofri now available for schizophrenia; setmelanotide shows promise in hypothalamic obesity; GLP-1RAs may reduce dementia risk.
Source: www.empr.comCategories: General Medicine NewsTweet-
👂 New MPR Pod out now! 🔹Uplizna gains new indication; 🔸Vanrafia approved for proteinuria in IgAN; 🔹Erzofri now available for schizophrenia; 🔸Setmelanotide shows promise for hypothalamic obesity; and 🔹GLP-1RAs may reduce dementia risk. https://t.co/YLwhozqPrt https://t.co/1dPba9Wq6S
-
-
Mashup Score: 0
Patients carrying 2 copies of the APOE4 gene (APOE4/4 homozygotes) are more likely to develop AD earlier in life than those without APOE4.
Source: www.empr.comCategories: General Medicine NewsTweet-
A nominally significant cognitive benefit was observed in valiltramiprosate-treated patients at the mild cognitive impairment stage of Alzheimer disease. https://t.co/0ugazOStxW
-
-
Mashup Score: 0
Kennedy can’t force communities to stop fluoridating water, but he can influence the CDC’s recommendations and work with the EPA to change the allowed limits. HealthDay News — US Health Secretary Robert F. Kennedy Jr. says he will tell the US Centers for Disease Control and Prevention (CDC) to stop recommending fluoride in drinking water across the country. He also announced plans to form a special task force to focus on health risks of fluoride. Kennedy made the comments Monday during a media event with
Source: www.empr.comCategories: General Medicine NewsTweet-
Kennedy can’t force communities to stop fluoridating water, but he can influence the CDC’s recommendations and work with the EPA to change the allowed limits. https://t.co/9Pf5z9IUY1 https://t.co/qHsItBLDFD
-
-
Mashup Score: 0Study Suggests GLP-1RAs May Reduce Dementia Risk - 19 day(s) ago
A statistically significantly lower risk of dementia or cognitive impairment was observed with GLP-1RAs, though not with SGLT2is or pioglitazone.
Source: www.empr.comCategories: General Medicine NewsTweet-
A lower risk of dementia or cognitive impairment was observed with GLP-1RAs use but not with SGLT2is. https://t.co/YVUMM8RKbI
-
-
Mashup Score: 0
Oz has made millions of dollars over the years selling dietary supplements and promoting health-related companies.
Source: www.empr.comCategories: General Medicine NewsTweet-
Mehmet Oz, who made millions of dollars over the years selling dietary supplements and promoting health-related companies, confirmed as Medicare & Medicaid head. https://t.co/hnJ1RJszrh
-
-
Mashup Score: 0
The approval was based on data from the randomized, 3-arm, open-label CHECKMATE-8HW trial.
Source: www.empr.comCategories: General Medicine News, General Journals & SocietTweet-
Combined therapy approved for colorectal cancer; study shows a 79% reduction in death with the treatment. https://t.co/P38Ay0vUhv
-
-
Mashup Score: 0March 2025: Notable Drug Approvals - 21 day(s) ago
March 2025 notable drug approvals.
Source: www.empr.comCategories: General Medicine NewsTweet-
All the new drug approvals you need to know about that happened in March. https://t.co/hd69C3AJaw https://t.co/UVLKwD6vZx
-
Pfizer decides to stop work on it's weight loss drug. https://t.co/wfb3P5gCF7